InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by HANDLEY DANIEL E, Director. Director active across 1 companies, notably Predictive Oncology Inc.. Cumulatively, 9 filings have been logged. Total volume traded: €2k. The latest transaction was disclosed on 26 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€8902,550 shares@ €0.349149.3% of flow
Common Stock
SEC:0001415889-22-005765:0·
Ideal exit: 20 Feb 2023 (T+270)
€9172,800 shares@ €0.327550.7% of flow
Common Stock
SEC:0001415889-22-005639:0·
Ideal exit: 19 Feb 2023 (T+270)
06,142 shares0
Common Stock
SEC:0001415889-22-003761:0·
014,709 shares0
Common Stock
SEC:0001179110-22-000323·
014,709 shares0
Common Stock
SEC:0001179110-22-000323:0·
04,512 shares0
Common Stock
SEC:0001179110-21-009202·
04,512 shares0
Common Stock
SEC:0001179110-21-009202:0·
09,924 shares0
Common Stock
SEC:0001179110-21-007387·
09,924 shares0
Common Stock
SEC:0001179110-21-007387:0·
9 of 9 declarations
About HANDLEY DANIEL E
Daniel E. Handley serves as a Board Member at Predictive Oncology Inc. He brings valuable expertise in overseeing operations and the company's strategy. His role involves contributing to key decision-making and ensuring compliance with best governance practices. With significant experience in the industry, Daniel E. Handley helps guide the company towards sustainable growth and maximizes shareholder value. His commitment to innovation and operational excellence is an asset to the organization.
